In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody

Krueger, J. G., Kim, B. S., Weidinger, S., Kataoka, Y., O’malley, J. T., Yen, K., … Vela, J. (2025). In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody. Acta Dermato-Venereologica. Medical Journals Sweden AB. https://doi.org/10.2340/actadv.v105.43608